Program
Tolvaptan
Also written as “OPC-41061”, “tolvaptan” and “Tolvaptan MR”.
Its studies are mostly in Polycystic Kidney, Autosomal Dominant · Hyponatremia · Heart Failure · Fibrosis · Kidney Failure, Chronic, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Otsuka | 541 open or running | phase 4since Sep 15, 2011 | Aug 13, 2002 | Dec 28, 2028phase 3 · NCT04782258 |
| Jiangsu HengRui Medicine | 10 open or running | phase 3since Jan 5, 2012 | Jan 5, 2012 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 38 studies since Aug 13, 2002.
- Dec 9, 2013Phase 2 study in Inappropriate ADH SyndromeOtsuka · NCT02009878 · 30 enrolled · Czech Republic, Denmark, Germany and more
- Dec 11, 20132 phase 3 studies in HyponatremiaOtsuka · NCT02012959, NCT02020278
- Jun 6, 2014Phase 3 study in Renal Insufficiency, ChronicOtsuka · NCT02160145 · 1,370 enrolled · United States, Argentina, Australia and more
- Sep 25, 2014Phase 3 study in Polycystic Kidney, Autosomal DominantOtsuka · NCT02251275 · 1,803 enrolled · United States, Argentina, Australia and more
- Dec 23, 2014Phase 2 study in Kidney Failure, ChronicOtsuka · NCT02331680 · 124 enrolled · Japan
- May 8, 20152 phase 3 studies in HyponatremiaOtsuka · NCT02442674, NCT02449044
- Sep 15, 2016Phase 3 study in Polycystic Kidney, Autosomal DominantOtsuka · NCT02964273 · 91 enrolled · Belgium, Germany, Italy and more
- Dec 13, 2016Phase 1 study in Healthy Adult MaleOtsuka · NCT02994394 · 84 enrolled · Japan
- Feb 7, 2017Phase 3 study in Inappropriate ADH SyndromeOtsuka · NCT03048747 · 16 enrolled · Japan
- Aug 18, 2017Phase 3 study in Heart FailureOtsuka · NCT03255226 · 60 enrolled · Japan
- Apr 16, 2019Phase 4 study in Polycystic Kidney, Autosomal DominantOtsuka · NCT03949894 · 118 enrolled · Korea, Republic of
- Feb 19, 20212 phase 3 studies in Polycystic Kidney, Autosomal RecessiveOtsuka · NCT04786574, NCT04782258
- Aug 22, 20252 phase 1 studiesOtsuka · NCT07166887, NCT07166783
- Oct 23, 2026Primary completion moved from 2028-07-31 to 2028-12-28Date moved laterphase 3 · +5 months · NCT04782258
Ahead
- Dec 28, 2028Primary completion: phase 3 study in Polycystic Kidney, Autosomal RecessiveOtsuka · NCT04782258
TargetBeta
“An orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia”NCIt, by rule
“Vasopressin V2 receptor antagonist”ChEMBL 37, by rule
Studies
All 55 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07166887Healthy Subjects | 1 | Completed | Otsuka | Jul 27, 2011 | 12 |
| NCT07166783Health Subjects | 1 | Completed | Otsuka | Jul 4, 2011 | 10 |
| NCT04786574Polycystic Kidney, Autosomal Recessive | 3 | Withdrawn | Otsuka | Dec 10, 2025 | 0 |
| NCT04782258Polycystic Kidney, Autosomal Recessive · United States, Belgium, Germany and more | 3 | Recruiting | Otsuka | Dec 28, 2028 | 20 |
| NCT03949894Polycystic Kidney, Autosomal Dominant · Korea, Republic of | 4 | Completed | Otsuka | May 25, 2022 | 118 |
| NCT03255226Heart Failure · Japan | 3 | Completed | Otsuka | Jul 11, 2021 | 60 |
| NCT03048747Inappropriate ADH Syndrome · Japan | 3 | Completed | Otsuka | Mar 19, 2019 | 16 |
| NCT02994394Healthy Adult Male · Japan | 1 | Completed | Otsuka | Feb 28, 2017 | 84 |
| NCT02964273Polycystic Kidney, Autosomal Dominant · Belgium, Germany, Italy and more | 3 | Completed | Otsuka | Nov 17, 2021 | 91 |
| NCT02449044Hyponatremia | 3 | Completed | Otsuka | Oct 2009 | 111 |
| NCT02442674Hyponatremia | 3 | Withdrawn | Otsuka | Jun 22, 2017 | 0 |
| NCT02331680Kidney Failure, Chronic · Japan | 2 | Completed | Otsuka | May 2016 | 124 |
| NCT02251275Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Otsuka | Nov 9, 2018 | 1,803 |
| NCT02160145Renal Insufficiency, Chronic · United States, Argentina, Australia and more | 3 | Completed | Otsuka | Apr 18, 2017 | 1,370 |
| NCT02020278Hyponatremia · United States, Belgium, Czechia and more | 3 | Terminated | Otsuka | Oct 23, 2017 | 3 |
| NCT02012959Hyponatremia · United States, Italy, United Kingdom | 3 | Terminated | Otsuka | Jul 24, 2017 | 9 |
| NCT02009878Inappropriate ADH Syndrome · Czech Republic, Denmark, Germany and more | 2 | Completed | Otsuka | Jun 2015 | 30 |
| NCT01895322Kidney Failure, Chronic · Japan | 2 | Completed | Otsuka | Feb 2014 | 20 |
| NCT01876381Kidney Failure, Chronic · Japan | 2 | Completed | Otsuka | Feb 2014 | 26 |
| NCT02352285Heart Failure With Hyponatremia · Korea, Republic of | 4 | Terminated | Otsuka | Jan 2017 | 58 |
| NCT01684202Carcinomatous Edema · Japan | 2 | Completed | Otsuka | Dec 2013 | 43 |
| NCT01651156Edema, Cardiac · China | 3 | Completed | Otsuka | Jul 2013 | 244 |
| NCT01618448Edema, Cardiac · Taiwan | 3 | Completed | Otsuka | May 2014 | 85 |
| NCT01552590Hyponatremia · Korea, Republic of | 4 | Terminated | Otsuka | Apr 2012 | 74 |
| NCT01507727Hyponatremia · China | 3 | UNKNOWN | Jiangsu HengRui Medicine | Sep 2012 | 240 |
| NCT01451827Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Otsuka | Jul 2013 | 178 |
| NCT01439009Heart Failure · Japan | 4 | Completed | Otsuka | Mar 2014 | 100 |
| NCT01349348Ascites · China | 3 | Completed | Otsuka | May 2012 | 535 |
| NCT01336972Polycystic Kidney, Autosomal Dominant · Netherlands | 2 | Completed | Otsuka | Nov 2011 | 29 |
| NCT01280721Autosomal Dominant Polycystic Kidney Disease (ADPKD) · Japan | 3 | Completed | Otsuka | Aug 2014 | 135 |
| NCT01227512Hyponatremia · United States | 3 | Terminated | Otsuka | May 2013 | 124 |
| NCT01214421Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Otsuka | Feb 29, 2016 | 1,083 |
| NCT01210560Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Otsuka | Jun 2011 | 25 |
| NCT01114828Fibrosis · Japan | 3 | Completed | Otsuka | Oct 2011 | 40 |
| NCT01359462Liver Cirrhosis · China | 1 | Completed | Otsuka | Nov 2009 | 11 |
| NCT01349335Ascites · China | 2 | Completed | Otsuka | Jan 2010 | 180 |
| NCT01050530Fibrosis · Japan | 3 | Completed | Otsuka | Feb 2012 | 162 |
| NCT01048788Fibrosis · Japan | 3 | Completed | Otsuka | Aug 2011 | 51 |
| NCT01022424Polycystic Kidney, Autosomal Dominant · Japan | 3 | Completed | Otsuka | Jul 2014 | 13 |
| NCT00841568Polycystic Kidney, Autosomal Dominant · Japan | 2 | Completed | Otsuka | Nov 2010 | 17 |
| NCT00664014Hyponatremia · China | 2 | Completed | Otsuka | Feb 2010 | 241 |
| NCT00550459Hyponatremia · United States | 3 | Completed | Otsuka | Feb 2009 | 57 |
| NCT00544869Edema, Cardiac · Japan | 3 | Completed | Otsuka | Feb 2009 | 52 |
| NCT00525265Edema, Cardiac · Japan | 3 | Completed | Otsuka | Jan 2009 | 20 |
| NCT00479336Fibrosis · Japan | 2 | Completed | Otsuka | Jan 2009 | 104 |
| NCT00462670Edema, Cardiac · Japan | 3 | Completed | Otsuka | Oct 2008 | 110 |
| NCT00428948Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Otsuka | Jan 2012 | 1,445 |
| NCT00413777Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Otsuka | Jun 2010 | 46 |
| NCT00234104Heart Failure · Japan | 2 | Completed | Otsuka | Jan 2006 | 122 |
| NCT00201994Hyponatremia · Germany | 3 | Completed | Otsuka | Jul 1, 2005 | 243 |
| NCT00132886Heart Failure · United States, Romania | 2 | Completed | Otsuka | Dec 2006 | 140 |
| NCT00072683Hyponatremia · United States | 3 | Completed | Otsuka | Dec 1, 2005 | 205 |
| NCT00071331Heart Failure · United States, Argentina, Belgium and more | 3 | Completed | Otsuka | Jul 2006 | 3,600 |
| NCT00043771Heart Failure · United States | 2 | Completed | Otsuka | 40 | |
| NCT00043758Heart Failure · United States, Canada | 2 | Completed | Otsuka | 170 |
How it is read
Names in the registry
- “Tolvaptan”, 30 entries
- “OPC-41061”, 12 entries
- “tolvaptan”, 6 entries
- “Tolvaptan MR”, 5 entries
- “OPC-41061(Tolvaptan)”, 3 entries
Conditions, from the studies’ own filings
- Polycystic Kidney, Autosomal Dominant, 12 studies
- Hyponatremia, 11 studies
- Heart Failure, 8 studies
- Fibrosis, 4 studies
- Kidney Failure, Chronic, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.